Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT05425745Phase 3Completed
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.
DyslipidemiasFamilial HypercholesterolemiaGenetic Disease, Inborn+6 more
StudydirectorStart date: 2022-07-25
NCT05266586Phase 2Completed
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
DyslipidemiasHigh CholesterolHypercholesterolemia
StudydirectorStart date: 2022-03-09
NCT05142722Phase 3Completed
Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies
Atherosclerotic Cardiovascular DiseaseDyslipidemiasFamilial Hypercholesterolemia+2 more
StudydirectorStart date: 2021-12-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05425745Phase 3StudyDirector

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

DyslipidemiasFamilial HypercholesterolemiaGenetic Disease, Inborn+6 more
Completed
NCT05266586Phase 2StudyDirector

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

DyslipidemiasHigh CholesterolHypercholesterolemia
Completed
NCT05142722Phase 3StudyDirector

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

Atherosclerotic Cardiovascular DiseaseDyslipidemiasFamilial Hypercholesterolemia+2 more
Completed

All 3 trials loaded